| Name | Paper | Description of Comparison | Gene | RSID | Association | Disease Status | MAF | Statistical Odds Ratio | Statistical P-value |
| Namkoong_rs13050728 | Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan | COVID-19 vs control | IFNAR2 | rs13050728 | Positive | Susceptibility | 0.573 | 1.1 | 0.015 |
| Namkoong_rs13050728 | Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan | Young COVID-19 vs control | IFNAR2 | rs13050728 | Positive | Susceptibility | 0.58 | 1.16 | 0.0024 |
| Namkoong_rs13050728 | Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan | Young severe COVID-19 vs contr | IFNAR2 | rs13050728 | Positive | Severe | 0.605 | 1.28 | 0.0039 |
| COVID-19 HGI_rs13050728 | Mapping the human genetic architecture of COVID-19 | Hospitalised vs Controls | IFNAR2 | rs13050728 | Negative | Severe | 0.651 | 0.861 | 0.0000000000000000000272 |
| COVID-19 HGI_rs13050728 | Mapping the human genetic architecture of COVID-19 | Critical vs Controls | IFNAR2 | rs13050728 | Negative | Critical | 0.652 | 0.819 | 0.000000000000000105 |
| Pairo-Castineira_rs13050728 | Genetic mechanisms of critical illness in Covid-19 | Hospitalised vs Controls | IFNAR2 | rs13050728 | Positive | Severe | None | 1.2 | 0.0000000000051 |
